Literature DB >> 2467129

Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations.

M A Matlib1, J F French, I L Grupp, C Van Gorp, G Grupp, A Schwartz.   

Abstract

Amlodipine inhibited contractions of rat aortic rings induced by 40 mM KCl (IC50 = 7.5 x 10(-9) M). The time to attain the maximum inhibitory effect of KCl-induced contractions was long (hours) and dependent on the concentration of amlodipine. After 6 h of washing in drug-free normal Krebs-Ringer solution the contractions recovered only partially. The KCl-induced contractions appeared to be more sensitive to inhibition by amlodipine than were norepinephrine-induced contractions. CaCl2-induced contraction of KCl-depolarized aortic rings was inhibited by amlodipine in a complex manner. Amlodipine not only increased ED50 but also inhibited the maximal tension induced by CaCl2. Amlodipine also inhibited 35 mM KCl-induced contractions of pig coronary artery rings (IC50 = 2.2 x 10(-8) M) and human coronary artery rings (IC50 = 2.1 x 10(-8) M). In Langendorff rat heart preparations, low concentrations of amlodipine increased coronary flow (ED50, 10(-9) M) whereas higher concentrations (greater than 10(-7) M) decreased coronary flow. Amlodipine also decreased the rate of contraction (+ dP/dt, IC50 = 3 x 10(-7) M) and the rate of relaxation (-dP/dt, IC50 = 1.2 x 10(-7) M). Amlodipine decreased heart rate but only at high concentrations (greater than 300 nM). The results of this study indicate that amlodipine is a potent vasodilator with similar cardiovascular actions to other dihydropyridines except that its effects are slower in onset and longer lasting.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2467129     DOI: 10.1097/00005344-198812007-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  D Murdoch; R C Heel
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  (+)-S-12967 and (-)-S-12968: 1,4-dihydropyridine stereoisomers with calcium channel agonistic and antagonistic properties in rat resistance arteries.

Authors:  D Prieto; M J Mulvany; N C Nyborg
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

3.  Antianginal effects of amlodipine at a single dose on exertional angina patients using treadmill exercise testing--a randomized crossover study in comparison with placebo.

Authors:  H Kishida; N Hata; T Kunimi; H Miyagawa; H Nishiyama; K Katoh
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

4.  Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.

Authors:  P Santarelli; F Biscione; A Natale; A Manzoli; G A Lanza
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

5.  Lipid emulsion inhibits the vasodilation induced by a toxic dose of amlodipine in isolated rat aortae.

Authors:  Seong-Ho Ok; Soo Hee Lee; Ji-Yoon Kim; Hyun-Jin Kim; Sung Il Bae; Yeran Hwang; Seongyeong Tak; Ju-Tae Sohn
Journal:  Int J Med Sci       Date:  2019-11-09       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.